ESR1 and multiple sclerosis: Other drugs that showed opposite gene expression perturbations in drug versus ASD at p < 0.1 included the anticonvulsants lamotrigine and topiramate, the selective estrogen receptor modulator raloxifene, the anti-cancer drug vemurafenib, the anesthetic agent tetracaine, and dalfampridine (used in Multiple Sclerosis).